This is history in the making. For the first time ever, the Federal Drug Administration approved a drug featuring an active component from cannabis. Epidiolex, which has been in Stage 3 testing since 2015, is now approved as a prescription treatment for two rare and lethal forms of epilepsy: Dravet’s and Lennox-Gastaut Syndrome. Finally, the […]
Cannabidiol is going mainstream with two CBD drugs getting the green light from the FDA. Epidiolex, is a 98% pure, botanical origin CBD drug proving effective for treatment of epilepsy. Specifically, the Dravet and Lennox-Gastaut syndrome versions. This is not the first time the FDA has given permissions to a CBD drug. Back in 2015, […]
Surprise! Despite the pro-cannabis public scorn, the FDA is not as anti-cannabinoids as one may think. Contrarily, the FDA addresses the questions and pressures about CBD products readily. While there is no branded “FDA CBD drug” there has been historic progress regarding just that. The FDA is in agreement with pre-clinical trials for CBD treatment […]